We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PCOR:NYSEProcore Technologies, Inc. Analysis

Data as of 2026-07-06 - not real-time

$44.04

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Procore Technologies is trading below its short‑term and intermediate moving averages, indicating short‑term weakness, yet the MACD histogram has turned positive and volume is rising, suggesting a potential bounce off the identified support level. The RSI hovers around the neutral midpoint, reinforcing the lack of extreme momentum, while the 30‑day volatility remains elevated, reflecting a turbulent price environment. Fundamentals show solid top‑line growth and a healthy cash position, but profitability remains negative and margins are thin, keeping earnings pressure high. The discounted cash flow model places intrinsic value near the current market price, implying the stock is fairly valued at present, with a sizable upside potential relative to its downside risk.
The sector’s growth narrative, driven by AI‑enhanced construction software, aligns with the company’s recent strategic acquisition, but execution risk and a high price‑to‑book multiple temper enthusiasm. Investors should weigh the bullish technical signs against the lingering earnings challenges and sector volatility when deciding on exposure.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • price approaching a clear technical support zone
  • bullish MACD histogram indicating momentum shift
  • rising trading volume supporting a potential rebound

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • sustained revenue growth and expanding cash reserves
  • forward earnings estimates turning positive
  • DCF fair‑value estimate aligning with current market price

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • ongoing profitability challenges and thin margins
  • high price‑to‑book multiple relative to peers
  • execution risk surrounding AI integration and recent acquisition

Key Metrics & Analysis

Financial Health

Revenue Growth15.70%
Profit Margin-5.61%
P/E Ratio20.9
ROE-6.46%
ROA-2.74%
Debt/Equity7.75
P/B Ratio5.5
Op. Cash Flow$311.0M
Free Cash Flow$246.1M
Industry P/E36.6

Technical Analysis

TrendBearish
RSI50.7
Support$38.03
Resistance$52.00
MA 20$42.15
MA 50$47.71
MA 200$61.33
MACDBullish
VolumeIncreasing
Fear & Greed Index93.63

Valuation

Fair Value$44.48
Target Price$69.00
Upside/Downside56.68%
GradeFair
TypeGrowth

Risk Assessment

Beta1.02
Volatility59.31%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.